Brief: Fulgent Genetics Q3 Revenue USD 71.743 Million
08/11/2024 12:00
Nov 08 (Reuters) - Fulgent Genetics Q3 pretax profit USD -18.532 million. * Q3 operating income USD -17.079 million * Q3 gross profit USD 26.771 million * Q3 operating expenses USD 43.85 million * Q3 core revenue USD 71.7 million * Q3 adjusted EBITDA USD 400 thousand
Recent news on Fulgent Genetics
See all newsU.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
Fulgent Genetics Inc reports results for the quarter ended June 30 - Earnings Summary
Fulgent Genetics Q2 revenue rises 20% sequentially, sees billing system transition delay
Brief: Fulgent Genetics Q2 Revenue USD 85.389 Million
Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview